Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4UMU

Structure of MELK in complex with inhibitors

4UMU の概要
エントリーDOI10.2210/pdb4umu/pdb
関連するPDBエントリー4UMP 4UMQ 4UMR 4UMT
分子名称Maternal embryonic leucine zipper kinase, (2-ethoxy-4-{[3-(isoquinolin-7-yl)prop-2-yn-1-yl]oxy}phenyl)methanaminium (3 entities in total)
機能のキーワードtransferase, fragment based drug design, kinase
由来する生物種Homo sapiens (human)
細胞内の位置Cell membrane ; Peripheral membrane protein : Q14680
タンパク質・核酸の鎖数1
化学式量合計41255.71
構造登録者
主引用文献Johnson, C.N.,Adelinet, C.,Berdini, V.,Beke, L.,Bonnet, P.,Brehmer, D.,Calo, F.,Coyle, J.E.,Day, P.J.,Frederickson, M.,Freyne, E.J.E.,Gilissen, R.A.H.J.,Hamlett, C.C.F.,Howard, S.,Meerpoel, L.,Mevellec, L.,Mcmenamin, R.,Pasquier, E.,Patel, S.,Rees, D.C.,Linders, J.T.M.
Structure-Based Design of Type II Inhibitors Applied to Maternal Embryonic Leucine Zipper Kinase.
Acs Med.Chem.Lett., 6:31-, 2015
Cited by
PubMed Abstract: A novel Type II kinase inhibitor chemotype has been identified for maternal embryonic leucine zipper kinase (MELK) using structure-based ligand design. The strategy involved structural characterization of an induced DFG-out pocket by protein-ligand X-ray crystallography and incorporation of a slender linkage capable of bypassing a large gate-keeper residue, thus enabling design of molecules accessing both hinge and induced pocket regions. Optimization of an initial hit led to the identification of a low-nanomolar, cell-penetrant Type II inhibitor suitable for use as a chemical probe for MELK.
PubMed: 25589926
DOI: 10.1021/ML5001273
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.02 Å)
構造検証レポート
Validation report summary of 4umu
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon